E-cigarette sales dropped in 2022 following a spike; President Joe Biden will sign an executive order designed to guard and expand contraception access; Ochsner Health and MD Anderson Cancer Center are partnering to serve patients in Louisiana with cancer.
E-Cigarette Sales Decline in 2022 After Spike
E-cigarette sales grew by almost 47% from January 2020 before the pandemic struck the United States, according to an analysis announced Thursday by the CDC and reported by The New York Times. The growth over that time happened while teenagers and young adults noted in surveys that they lately tried e-cigarettes at considerably higher rates than older adults. The CDC said that around 4.5% of all adults said they used e-cigarettes, but rates increased as age decreased. Sales grew through May of 2022, then dropped by 12% through December, which could be due to state or local bans on flavored e-cigarettes, government enforcement, or the introduction of other devices.
Biden Will Sign Order to Extend Contraception Access
President Joe Biden on Friday will sign an executive order created to protect and increase access to contraception after a Supreme Court ruling in 2022 overturned the constitutional right to abortion elevated fears that birth control might also be restricted, according to Reuters. Senior advisor to President Biden, Jen Klein, informed reporters that the order will increase contraception access for women and decrease out-of-pocket costs. The president’s announcement emerges as reproductive rights advocates express that growing obstacles are leaving millions of women without easy contraception access.
Ochsner Health, MD Anderson Partner in Louisiana
Ochsner Health and the University of Texas MD Anderson Cancer Center are partnering to create an integrated cancer care program in southeastern Louisiana they said on Thursday, according to Fierce Healthcare. The new integration will be called the Ochsner MD Anderson Cancer Center and will be the first to carry MD Anderson’s best practices and clinical leadership to Louisiana’s patients with cancer. It comes as the seventh arrangement MD Anderson created with large-scale health systems.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen